Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 - HI TECH PHARMACAL CO INCdex312.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - HI TECH PHARMACAL CO INCdex211.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 - HI TECH PHARMACAL CO INCdex311.htm
EX-23.1 - CONSENT OF EISNERAMPER LLP - HI TECH PHARMACAL CO INCdex231.htm
10-K - FOR THE FISCAL YEAR ENDED APRIL 30, 2011 - HI TECH PHARMACAL CO INCd10k.htm

EXHIBIT 32.1

HI-TECH PHARMACAL CO., INC.

CERTIFICATION PURSUANT TO 18 U. S. C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE

SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Hi-Tech Pharmacal Co., Inc. (the “Company”), hereby certify to such officers’ knowledge, that the Company’s Annual Report on Form 10-K for the year ended April 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: July 11, 2011
/s/ David Seltzer
David Seltzer,

Chief Executive Officer

/s/ William Peters

William Peters,

Chief Financial Officer

This certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.